CATHERINE WARNER: Open Payments
NPI 1710220249 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$50,629 in 112 payments from 20 companies in 2025. Trend: 2023 $7,409 · 2024 $1,662 · 2025 $50,629
Honoraria: $34,200Travel & lodging: $7,292Consulting: $6,336Food & beverage: $2,795Education: $7
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 39 | $41,722 |
| GENZYME CORPORATION | 14 | $7,691 |
| PFIZER INC. | 22 | $388 |
| Regeneron Healthcare Solutions, Inc. | 8 | $217 |
| ABBVIE INC. | 5 | $107 |
| Botanix SB Inc | 3 | $59 |
| Incyte Corporation | 2 | $57 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Verrica Pharmaceuticals Inc. | 2 | $42 |
Products named: VTAMA, DUPIXENT, CIBINQO, LITFULO, RINVOQ, SOFDRA, OPZELURA, SKYRIZI.
Industry payments across GA — which companies pay providers there.
